Skip to content

Clinical trials

Completed Essential Hypertension trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Essential Hypertension Status: Completed Country / region: France Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20082
20092
20101
20112
20124
20151
20181
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Quantum Genomics SA3
Assistance Publique - Hôpitaux de Paris2
Daiichi Sankyo2
Novartis2
University Hospital, Rouen2
Ablative Solutions, Inc.1
Novartis Pharmaceuticals1
RECORDATI GROUP1
Sankyo Pharma Gmbh1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Essential Hypertension17
Hypertension6
Cardiovascular Diseases2
Edema1
Hyperaldosteronism1
Metabolic Syndrome1
Paraganglioma1
Pheochromocytoma1
Vascular Diseases1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.